Humacyte (HUMA) Price to Earnings (2021 - 2022)
Humacyte's Price to Earnings came in at 9.79 for Q3 2022, down 16.9% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Price to Earnings (2021 - 2022) Analysis & Trends
- The Q3 2022 figure represents the lowest quarterly Price to Earnings since Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.99 Bn | 1,097.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.51 Bn | 554.37 Bn | 17.30 Bn |
| 3 | AbbVie | 505.90 Bn | 479.01 Bn | 12.70 Bn |
| 4 | Merck | 357.53 Bn | 311.91 Bn | 12.21 Bn |
| 5 | Novartis Ag | 289.94 Bn | 253.93 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.41 Bn | 239.09 Bn | 12.86 Bn |
| 7 | Amgen | 238.14 Bn | 193.54 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | Humacyte | 100.44 Mn | -98.00 Mn | -825,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 9.79 |
| Jun 30, 2022 | 11.78 |
| Jun 30, 2021 | 3.58 |
API Access
Humacyte Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();